Neurocardiogenic Syncope

Also known as: Vagal reaction / Vagal Activity / Vaso vagal attack / Syncope/vasovagal faint / Vasovagal attack / Blackout / Syncope vagovagal / Vasovagal reaction / Syncope, Vasovagal / Syncope vasovagal / Presyncope / Pre-syncope / Near syncope

DrugDrug NameDrug Description
DB00986GlycopyrroniumGlycopyrronium (as the bromide salt glycopyrrolate) is a synthetic anticholinergic agent with a quaternary ammonium structure. A muscarinic competitive antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics. In October 2015, glycopyrrolate was approved by the FDA for use as a standalone treatment for Chronic obstructive pulmonary disease (COPD), as Seebri Neohaler.
DB00424HyoscyamineHyoscyamine is a chemical compound, a tropane alkaloid it is the levo-isomer to atropine. It is a secondary metabolite of some plants, particularly henbane (Hyoscamus niger.) Hyoscyamine is used to provide symptomatic relief to various gastrointestinal disorders including spasms, peptic ulcers, irritable bowel syndrome, pancreatitis, colic and cystitis. It has also been used to relieve some heart problems, control some of the symptoms of Parkinson's disease, as well as for control of respiratory secretions in end of life care.
DrugDrug NamePhaseStatusCount
DB05708GTS-21Not AvailableCompleted1